Stephen J. Tulipano, CFO at Stoke Therapeutics, Inc. (STOK), sold 54,898 shares at $59.29 ($3.2M) on 2021-02-22, disclosed to the SEC on 2021-02-24.
Open-market sale of $3.2M STOK by CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.67 | 15,202 | $892K | 27.6% |
| 2 | $58.67 | 15,202 | $892K | 27.6% |
| 3 | $59.29 | 9,696 | $575K | 17.8% |
| 4 | $59.29 | 9,696 | $575K | 17.8% |
| 5 | $60.00 | 102 | $6K | 0.2% |
| 6 | $58.60 | 5,000 |
| $293K |
| 9.1% |
| Total | $58.89 avg | 54,898 | $3.2M | 100% |
| Filing → |
| ALDX | BUY | 2017-02-21 | $15K | — | Filing → |
| JAV | SELL | 2010-05-05 | $5K | — | Filing → |